A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie
about
Continuous quinacrine treatment results in the formation of drug-resistant prionsSafety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trialPharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporterAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected miceQuinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.Prion strain- and species-dependent effects of antiprion molecules in primary neuronal culturesPrion proteins: a biological role beyond prion diseases.Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.The potential of mesenchymal stem cell in prion research.Inhibition of Kir4.1 potassium channels by quinacrine.A review of drug therapy for sporadic fatal insomnia.Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.
P2860
Q21090510-13A7DE07-E6FB-42CC-B01C-9C38FE7CF72BQ24653364-E5E9F6C2-628F-4DF0-841F-C61711B5FE43Q28480949-79A1B8E3-006F-4FF6-AF40-6546DF36E76EQ30540027-C9C084FE-84A3-4786-9346-5B82A22B67A1Q33560026-F582A0F6-FF46-4259-BA19-F26E0D49D447Q33670676-E823F009-7112-465C-982A-90579ED7F2C8Q34415659-9349761A-D558-4D03-9220-FBECB05BA0B9Q36315218-D1EE027C-21A1-4D67-878E-57D998F7106BQ36895918-C0CEBCA9-AB66-4C6B-81AA-9DDB38AECF0CQ37725318-28072E15-7EAC-4887-BBDC-B2B8CD96510AQ38213991-96C62536-6C21-4539-AB64-2A5806732A81Q45054509-D191966F-1654-4828-B4B3-35764E481F28Q47678105-E80AB44C-1E2C-4B89-BDC4-5D2C02C6702BQ51277578-E6C98C83-969C-413B-A2CF-245FACC5980E
P2860
A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A possible pharmacological exp ...... ns in a ovine model of scrapie
@ast
A possible pharmacological exp ...... ns in a ovine model of scrapie
@en
A possible pharmacological exp ...... ns in a ovine model of scrapie
@nl
type
label
A possible pharmacological exp ...... ns in a ovine model of scrapie
@ast
A possible pharmacological exp ...... ns in a ovine model of scrapie
@en
A possible pharmacological exp ...... ns in a ovine model of scrapie
@nl
prefLabel
A possible pharmacological exp ...... ns in a ovine model of scrapie
@ast
A possible pharmacological exp ...... ns in a ovine model of scrapie
@en
A possible pharmacological exp ...... ns in a ovine model of scrapie
@nl
P2093
P2860
P921
P356
P1476
A possible pharmacological exp ...... ns in a ovine model of scrapie
@en
P2093
Catherine Viguié
Olivier Andréoletti
Pierre-Louis Toutain
Valerie Laroute
P2860
P304
P356
10.1038/SJ.BJP.0706072
P407
P577
2005-02-01T00:00:00Z